Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
37.1M
-
Shares change
-
+1.38M
-
Total reported value, excl. options
-
$308M
-
Value change
-
+$10.7M
-
Put/Call ratio
-
0.68
-
Number of buys
-
61
-
Number of sells
-
-35
-
Price
-
$8.30
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q4 2014
120 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2014.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.1M shares
of 56M outstanding shares and own 66.14% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (10.7M shares), Murphy Michael R (3.1M shares), Abingworth LLP (2.88M shares), ARDSLEY ADVISORY PARTNERS (1.89M shares), Ameriprise Financial Inc (1.47M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.42M shares), BlackRock Fund Advisors (1.33M shares), NORTHPOINTE CAPITAL LLC (981K shares), VANGUARD GROUP INC (822K shares), and MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC (762K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.